Home > Products > Novel inhibitors

PLK1-IN-2

  Cat. No.:  DC47377  
Chemical Structure
2640254-52-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
PLK1-IN-2 is a PLK1 kinase inhibitor with an IC50 value of 0.384 μM.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 2640254-52-8
Chemical Name: PLK1-IN-2
Formula: C24H27FN8Os
M.Wt: 494.59
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
TITLE DOWNLOAD
MSDS_31229_DC47377_2640254-52-8
COA
LOT NO. DOWNLOAD
Cat. No. Product name Field of application
DC47377 PLK1-IN-2 PLK1-IN-2 is a PLK1 kinase inhibitor with an IC50 value of 0.384 μM.
DC45897 Volasertib trihydrochloride Volasertib (BI 6727) trihydrochloride is an orally active, highly potent and ATP-competitive Polo-like kinase 1 (PLK1) inhibitor with an IC50 of 0.87 nM. Volasertib trihydrochloride inhibits PLK2 and PLK3 with IC50s of 5 and 56 nM, respectively. Volasertib trihydrochloride induces mitotic arrest and apoptosis. Volasertib trihydrochloride, a dihydropteridinone derivative, shows marked antitumor activity in multiple cancer models.
DC45827 BTO-1 BTO-1 is a Polo-like kinase (Plk) inhibitor. BTO-1 is primarily used for phosphorylation and dephosphorylation applications.
DC11635 Poloxin-2 A potent, selective PLK1 PBD inhibitor with IC50 of 1.36 uM.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia